Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Radioiodine ablation: when and how.

M C Ambrosetti1, C Colato, A Dardano

  • 1Department of Morphological and Biomedical Sciences, University of Verona, Verona, Italy.

The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of
|November 14, 2009
PubMed
Summary

Radioiodine (131I) ablation after thyroid surgery for differentiated thyroid cancer (DTC) is debated for smaller tumors. Recombinant human TSH (rhTSH) offers an alternative to improve treatment while preserving quality of life.

Related Concept Videos

Radiological Investigation III: Pulmonary Angiogram and PET Scan01:13

Radiological Investigation III: Pulmonary Angiogram and PET Scan

Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical presentation and prognosis of COVID-19 in older adults with hypothyroidism: data from the GeroCovid observational study.

Journal of endocrinological investigation·2023
Same author

Is non-thyroidal illness syndrome (NTIS) a clinical predictor of COVID-19 mortality in critically ill oldest old patients?

Journal of endocrinological investigation·2022
Same author

Characterization of innate immune response to Brucella melitensis infection in goats with permissive or restrictive phenotype for Brucella intramacrophagic growth.

Veterinary immunology and immunopathology·2021
Same author

High rate of pulmonary thromboembolism in patients with SARS-CoV-2 pneumonia.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2020
Same author

Optimum imaging of chronic pancreatitis.

Abdominal radiology (New York)·2020
Same author

Very-low-calorie ketogenic diet (VLCKD) in the management of metabolic diseases: systematic review and consensus statement from the Italian Society of Endocrinology (SIE).

Journal of endocrinological investigation·2019

Area of Science:

  • Endocrinology
  • Oncology
  • Nuclear Medicine

Background:

  • Differentiated thyroid cancer (DTC) incidence is rising globally.
  • Total thyroidectomy followed by radioiodine (131I) ablation is a standard DTC treatment.
  • The routine use of 131I ablation is increasingly debated for smaller tumors.

Purpose of the Study:

  • To review the advantages and disadvantages of postoperative radioiodine-induced thyroid remnant ablation in DTC patients.
  • To discuss the role of recombinant human TSH (rhTSH) as an alternative to traditional methods.

Main Methods:

  • Literature review of studies on differentiated thyroid cancer treatment.
  • Analysis of radioiodine ablation efficacy and side effects.
  • Evaluation of rhTSH in DTC management.

Related Experiment Videos

Main Results:

  • 131I ablation improves outcomes but carries risks like secondary malignancies and toxicity.
  • Individualized and selective approaches to 131I ablation are recommended.
  • rhTSH enhances radioiodine uptake without hypothyroidism, improving quality of life and reducing radiation dose.

Conclusions:

  • The decision for 131I remnant ablation should be individualized.
  • rhTSH presents a promising alternative for DTC treatment, balancing efficacy and patient well-being.
  • Further research is needed to fully elucidate long-term outcomes and risks.